Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-28

Clinical Trial Update: Effect of Use of Calcium Hydroxide and Metformin Intracanal Medicament After NSRCT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating calcium hydroxide and metformin as intracanal medicaments after non-surgical root canal therapy for apical periodontitis has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium hydroxide (calcium hydroxide)
  • metformin (metformin)

Snippet

Sponsor: Postgraduate Institute of Dental Sciences Rohtak | Conditions: Apical Periodontitis | Phase 2, Phase 3 | Status: COMPLETED